Drug Enforcement Administration October 20, 2006 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E6-17557
Type: Notice
Date: 2006-10-20
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E6-17556
Type: Notice
Date: 2006-10-20
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E6-17555
Type: Notice
Date: 2006-10-20
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E6-17554
Type: Notice
Date: 2006-10-20
Agency: Drug Enforcement Administration, Department of Justice
Solicitation of Information on the Use of Phenethylamine-Related Compounds
Document Number: E6-17523
Type: Notice
Date: 2006-10-20
Agency: Drug Enforcement Administration, Department of Justice
The DEA is soliciting information on substances that are related in chemical structure to phenethylamine (see supplementary information). The Controlled Substances Act (CSA), Title 21 of the United States Code (U.S.C.) Sec. 812(c) schedule I (Title 21 of the Code of Federal Regulations (CFR) Sec. 1308.11(d)), lists certain phenethylamines as schedule I controlled substances. Some phenethylamines that are not controlled under the CSA produce central nervous system effects that are similar to phenethylamines that are controlled under the CSA. DEA is requesting information to help determine the impact on business if these substances were to be placed under control in the CSA.
Schedules of Controlled Substances: Exempt Anabolic Steroid Products
Document Number: E6-17522
Type: Rule
Date: 2006-10-20
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is finalizing an Interim Rule designating two pharmaceutical preparations as exempt anabolic steroid products under the Controlled Substances Act. This action is part of the ongoing implementation of the Anabolic Steroids Control Act of 1990.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.